SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Pfizer informs about schedule of analyst meet

29 Jan 2019 Evaluate

Pursuant to Regulation 30 of the Listing Regulations, Pfizer has informed about the meeting scheduled with an Analyst/Institutional Investor on Tuesday, January 29, 2019 at Mumbai. This schedule shall also be displayed on the website of the company - www.pfizerindia.com in compliance with the Regulation 46 of the Listing Regulations.

The above information is a part of company’s filings submitted to BSE.

Pfizer Share Price

4850.45 39.40 (0.82%)
11-May-2026 11:22 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1883.75
Dr. Reddys Lab 1290.80
Cipla 1340.10
Zydus Lifesciences 943.70
Lupin 2250.05
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×